Next |
home / stock / rytm / rytm message board
Subject | By | Source | When |
---|---|---|---|
$RYTM what do you make of this data? | grich1 | investorshub | 04/27/2023 2:46:30 AM |
Do we have a winner?Turn around time? | Amatuer17 | investorshub | 04/19/2023 9:26:37 PM |
should we be shorting? | midastouch017 | investorshub | 04/17/2023 6:06:09 PM |
$RYTM The gaining up | Amatuer17 | investorshub | 04/16/2023 9:29:03 PM |
$RYTM MomentumIts trading up | bandit007 | investorshub | 04/15/2023 1:05:19 PM |
$RYTM The trading | pennyrich | investorshub | 04/14/2023 9:43:56 AM |
$RYTM When is this gonna take off? | Amatuer17 | investorshub | 04/14/2023 7:09:31 AM |
short squeeze article | Laszlo1 | investorshub | 04/13/2023 1:50:31 AM |
MomentumIts trading | Amatuer17 | investorshub | 04/12/2023 9:34:58 PM |
$RYTM The trading | midastouch017 | investorshub | 04/10/2023 6:13:57 AM |
$RYTM Price now | midastouch017 | investorshub | 04/06/2023 10:42:00 PM |
$RYTM bulls and bears | Amatuer17 | investorshub | 04/06/2023 2:03:44 PM |
MomentumIts now | Amatuer17 | investorshub | 04/04/2023 7:41:22 PM |
$RYTM MomentumIts now last trade up | midastouch017 | investorshub | 04/04/2023 7:23:50 PM |
In my view $ORMP is better than RYTM | midastouch017 | investorshub | 01/23/2023 4:28:26 PM |
znewcar1: f55,720M HOD24.6 got lead in the PPS | znewcar1 | investorshangout | 09/28/2022 5:17:28 PM |
znewcar1: Getting a few hits! needs vol >2.5M/d only v320K | znewcar1 | investorshangout | 09/28/2022 4:11:16 PM |
znewcar1: $RYTM HOD24.55 R25.5, 28+31 & #MOON HH43.26 last year what a turnaround! | znewcar1 | investorshangout | 09/28/2022 4:04:58 PM |
znewcar1: RYTM 24% V2,3m C30.85 F50,7m h30.98 ml20.11 | znewcar1 | investorshangout | 09/14/2022 10:14:05 PM |
znewcar1: RYTM 21% v2,0M c26.45 f50,7M H27.29 ML8.06 | znewcar1 | investorshangout | 08/16/2022 1:24:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Inc. Company Name:
RYTM Stock Symbol:
NASDAQ Market:
Rhythm Pharmaceuticals Inc. Website:
- European Commission decision anticipated in the second half of 2024 - BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rar...
2024-06-14 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- Participants from the completed Phase 2 hypothalamic obesity trial reported positive changes in sleep, energy levels during setmelanotide therapy in qualitative interviews - - Separate analysis of patients across MC4R pathway diseases showed one year of treatment with setmelanotide im...